IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951

Publication | Closed Access

DOI

103

Citations

References

2015

Year

Emmanuelle Clappier, Nathalie Grardel, Marleen Bâkkus, Jérôme Rapion, Barbara De Moerloose, Philippe Kastner, Aurélie Caye, J Vivent, V. Costa, Alina Ferster,

Leukemia

Hematological MalignancyEortc ChildrenMedicineMixed-phenotype Acute LeukemiaHematologyPathologyLeukemia GroupIkzf1 DeletionAdult T-cell Leukemia-lymphomaOncologyCell BiologyEpigeneticsCancer Research